Professor Robert Booy, infectious diseases paediatrician and Head of the Clinical Research team at the National Centre for Immunisation Research and Surveillance (NCIRS), agrees. ‘It’s the first step in the regulatory and then the approval process that will be required to figure out how to utilise this vaccine in Australian children – and hopefully we might have some more information emerging from other countries as we’re considering and thinking about those decisions.’ ‘It looks like the vaccine mounts an appropriate immune response in kids that would be needed to protect them from COVID-19, so it’s good news for kids and families,’ she said. Recorded side effects were also comparable to those observed in participants aged 16–25.Īs a paediatric infectious disease specialist and clinician scientist at Perth Children’s Hospital, Associate Professor Asha Bowen told newsGP she is pleased to see promising data coming through for younger children. One month after the second dose, the neutralising antibody geometric mean titre (GMT) for participants aged 5–.6 compared to 1146.5 for the control group. The 2268 participants received a two-dose regimen of 10 µg – a smaller dose than the 30 µg dose used to immunise people 12 and older – administered 21 days apart.īut despite the lower dosage, researchers found the antibody responses were comparable to those recorded in the control group, who were aged 16–25 and received 30 µg doses. Preliminary results from Pfizer’s phase 2/3 trials were released this week and reportedly show the mRNA vaccine is safe, well-tolerated, and produces a robust neutralising antibody response. There could soon be a COVID-19 vaccine for children aged 5–11. If Australia moves ahead on vaccinating 5–11-year-olds, paediatric infectious disease experts anticipate it likely will not be until next year. Preliminary results among children under 12 show promise, but larger trials will likely be needed to confirm that the benefits outweigh the risks.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |